Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

265 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-TNF-alpha therapy for sight threatening uveitis.
Lindstedt EW, Baarsma GS, Kuijpers RW, van Hagen PM. Lindstedt EW, et al. Among authors: van hagen pm. Br J Ophthalmol. 2005 May;89(5):533-6. doi: 10.1136/bjo.2003.037192. Br J Ophthalmol. 2005. PMID: 15834077 Free PMC article. Clinical Trial.
Is imatinib mesylate a promising drug in systemic sclerosis?
van Daele PL, Dik WA, Thio HB, van Hal PT, van Laar JA, Hooijkaas H, van Hagen PM. van Daele PL, et al. Among authors: van hagen pm, van laar ja, van hal pt. Arthritis Rheum. 2008 Aug;58(8):2549-52. doi: 10.1002/art.23648. Arthritis Rheum. 2008. PMID: 18668570 Free article.
Low level IGF-1 and common variable immune deficiency: an unusual combination.
van Bilsen K, Driessen GJ, de Paus RA, van de Vosse E, van Lom K, van Zelm MC, Lam KH, Hartwig NG, Baarsma GS, van de Burg M, van Hagen PM. van Bilsen K, et al. Among authors: van hagen pm, van lom k, van de burg m, van de vosse e, van zelm mc. Neth J Med. 2008 Oct;66(9):368-72. Neth J Med. 2008. PMID: 18931397 Free article.
Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.
van Steensel L, Paridaens D, Schrijver B, Dingjan GM, van Daele PL, van Hagen PM, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA. van Steensel L, et al. Among authors: van den bosch wa, van hagen pm, van daele pl. Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3091-8. doi: 10.1167/iovs.08-2443. Epub 2009 Feb 21. Invest Ophthalmol Vis Sci. 2009. PMID: 19234339
Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy.
van Steensel L, Paridaens D, Dingjan GM, van Daele PL, van Hagen PM, Kuijpers RW, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA. van Steensel L, et al. Among authors: van den bosch wa, van hagen pm, van daele pl. Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1002-7. doi: 10.1167/iovs.09-4338. Epub 2009 Sep 24. Invest Ophthalmol Vis Sci. 2010. PMID: 19797221
Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis.
Kamphuis LS, Lam-Tse WK, Dik WA, van Daele PL, van Biezen P, Kwekkeboom DJ, Kuijpers RW, Hooijkaas H, van Laar JA, Bastiaans J, Baarsma GS, van Hagen PM. Kamphuis LS, et al. Among authors: van hagen pm, van laar ja, van daele pl, van biezen p. Am J Respir Crit Care Med. 2011 Nov 15;184(10):1214-6. doi: 10.1164/ajrccm.184.10.1214. Am J Respir Crit Care Med. 2011. PMID: 22086995 Clinical Trial. No abstract available.
265 results